Villa Luca, Cloutier Jonathan, Cotè Jean-Francois, Salonia Andrea, Montorsi Francesco, Traxer Olivier
1 Department of Urology, Tenon Hospital, Pierre and Marie Curie University , Paris, France .
2 Division of Experimental Oncology, Unit of Urology , URI, IRCCS Ospedale San Raffaele, Milan, Italy .
J Endourol. 2016 Feb;30(2):237-42. doi: 10.1089/end.2015.0644. Epub 2015 Dec 30.
To describe our initial experience with confocal laser endomicroscopy (CLE) for the evaluation and treatment of patients with upper urinary tract transitional cell carcinoma (UUT-TCC).
Preliminary data were analyzed from 11 patients with suspicion of UUT-TCC scheduled for flexible ureteroscopy (f-URS) and consensual holmium-YAG laser tumor ablation. CLE was performed before endoscopic biopsy and laser photoablation of the suspected lesion using a 3F-diameter flexible probe UroFlex™ B (Cellvizio® system; Mauna Kea Technologies, Paris, France), which allows to obtain microscopic resolution imaging (3.5 μm), with a field of view of 325 μm and a depth of tissue imaging of 40 to 70 μm. Video sequences were analyzed offline and thereafter compared with histopathologic findings.
CLE technique was feasible and showed good quality imaging in all patients. Overall, the Cellvizio system provided reliable images of healthy urothelium when the probe was pointed toward normal tissue, showing umbrella cells on the surface and vessels in the lamina propria. Moreover, CLE displayed the characteristic features of high-density cellular aggregates and fibrovascular stalks in four patients with pathologically confirmed low-grade UUT-TCC. In the patient with pathologically confirmed high-grade UUT-TCC, more distorted microarchitecture and tortuous vessels were clearly recognized with CLE.
These preliminary data showed the feasibility of CLE technique when applied to the diagnosis of UUT-TCC. Further clinical studies are required to confirm CLE accuracy in distinguishing healthy urothelial tissue from malignant lesions, thus helping clinicians in targeting ureteroscopic biopsy and improving the conservative management of UUT-TCC patients.
描述我们使用共聚焦激光内镜显微镜(CLE)评估和治疗上尿路移行细胞癌(UUT-TCC)患者的初步经验。
分析了11例疑似UUT-TCC且计划接受软性输尿管镜检查(f-URS)和钬激光肿瘤消融术患者的初步数据。在对疑似病变进行内镜活检和激光光凝之前,使用直径3F的软性探头UroFlex™ B(Cellvizio®系统;法国巴黎莫纳克亚科技公司)进行CLE检查,该探头可获得微观分辨率成像(3.5μm),视野为325μm,组织成像深度为40至70μm。对视频序列进行离线分析,然后与组织病理学结果进行比较。
CLE技术可行且在所有患者中均显示出高质量成像。总体而言,当探头指向正常组织时,Cellvizio系统可提供健康尿路上皮的可靠图像,显示表面的伞细胞和固有层中的血管。此外,CLE在4例经病理证实为低级别UUT-TCC的患者中显示出高密度细胞聚集和纤维血管蒂的特征性表现。在经病理证实为高级别UUT-TCC的患者中,CLE清晰识别出更扭曲的微观结构和迂曲的血管。
这些初步数据表明CLE技术应用于UUT-TCC诊断的可行性。需要进一步的临床研究来证实CLE在区分健康尿路上皮组织与恶性病变方面的准确性,从而帮助临床医生靶向输尿管镜活检并改善UUT-TCC患者的保守治疗。